Overall cancer risk in Gaucher similar to that of general population
Gaucher disease patients are at higher risk of blood cancer, but the risk of solid tumors is similar to the general population, per a study.| Gaucher Disease News
October 13, 2025| Gaucher Disease News
Gaucher disease patients are at higher risk of blood cancer, but the risk of solid tumors is similar to the general population, per a study.| Gaucher Disease News
A bone marrow biopsy — a test that examines the soft tissue inside bones where blood cells are made — proved critical in diagnosing Gaucher disease (GD) in a boy in India with growth delays and a swollen abdomen. The biopsy revealed the presence of Gaucher cells (enlarged foamy immune cells that are a hallmark […] The post Bone marrow biopsy proves key to boy’s Gaucher diagnosis appeared first on Gaucher Disease News.| Gaucher Disease News
International Gaucher Day on Oct. 1 kicks off this year's awareness month, with a goal of shortening the diagnostic journey for patients.| Gaucher Disease News
Measuring levels of lyso-Gb1, a fatty molecule often used as a biomarker of Gaucher disease (GD) severity, could help improve the accuracy of diagnostic tests for the rare condition, according to a new report from a South American research team. While low activity of the glucocerebrosidase (GCase) enzyme is the diagnostic hallmark of Gaucher, unreliable […] The post Measuring lyso-Gb1 levels may aid diagnosis accuracy in Gaucher appeared first on Gaucher Disease News.| Gaucher Disease News
A 31-year-old woman with type 1 Gaucher disease (GD) experienced worsening symptoms and rising disease activity markers after switching from long-term enzyme replacement therapy (ERT) to Cerdelga (eliglustat), according to a recent case report. The woman — who was obese and had her spleen surgically removed years earlier — developed increasing fatigue, liver enlargement, and […] The post Obesity may affect SRT treatment response in Gaucher disease appeared first on Gaucher Disease News.| Gaucher Disease News
In Gaucher disease, the toxic buildup of a fatty molecule called glucosylsphingosine (lyso-Gb1) leads to issues with how nerve cells generate energy and other cellular problems, according to a new study. Lyso-Gb1 is a biomarker of disease burden and response to treatment. The findings help to understand how the accumulation of fatty molecules contributes to […] The post Fatty molecule may cause nerve cell damage in Gaucher: Study appeared first on Gaucher Disease News.| Gaucher Disease News
Treatment with a corticosteroid and hydroxychloroquine eased symptoms of severe lung problems in an infant with type 3 Gaucher disease.| Gaucher Disease News
A boy with Gaucher disease developed digestive complications related to lymph node issues despite receiving ERT treatment, per a case report.| Gaucher Disease News
